Cargando…
Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
BACKGROUND: Hepatitis C virus (HCV) effectively establishes persistent infection in human livers. The non-structural (NS) 3/4A complex participates in this process by cleavage of interferon β (IFNβ) promoter stimulator-1 (IPS-1; also termed Cardif/MAVS/VISA), which inhibits responses to double stran...
Autores principales: | Ahlén, G, Derk, E, Weiland, M, Jiao, J, Rahbin, N, Aleman, S, Peterson, D L, Pokrovskaja, K, Grandér, D, Frelin, L, Sällberg, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648966/ https://www.ncbi.nlm.nih.gov/pubmed/18689426 http://dx.doi.org/10.1136/gut.2007.147264 |
Ejemplares similares
-
Crystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain
por: Potter, Jane A, et al.
Publicado: (2008) -
Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model
por: Levander, Sepideh, et al.
Publicado: (2018) -
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
por: Burm, Rani, et al.
Publicado: (2023) -
BAG6 negatively regulates the RLR signaling pathway by targeting VISA/MAVS
por: Huang, Jing-Ping, et al.
Publicado: (2022) -
Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis
por: Koh, Eun Hee, et al.
Publicado: (2021)